Paper39944232
Decreased sirtuin 1 in type 2 diabetes patients with abnormal BMD.
Xu Y and 11 others. Front Endocrinol (Lausanne), 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Decreased sirtuin 1 in type 2 diabetes patients with abnormal BMD. Papers, record 39944232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39944232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Sirtuin 1 | Major topic |
| Bone Density | Major topic |
| Osteoporosis | Major topic |
| Bone Diseases, Metabolic | Major topic |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Biomarkers | |
| Aged | |
| Case-Control Studies | |
| Adult | |
| Absorptiometry, Photon |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33330467 | The Versatility of Sirtuin-1 in Endocrinology and Immunology. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33330467 | PubMed |
| 2 | 32717111 | Bone Turnover Markers Do Not Predict Fracture Risk in Type 2 Diabetes. | J Bone Miner Res | 2020 | https://conductscience.org/library/papers/32717111 | PubMed |
| 3 | 35307247 | Assessment and treatment of osteoporosis and fractures in type 2 diabetes. | Trends Endocrinol Metab | 2022 | https://conductscience.org/library/papers/35307247 | PubMed |
| 4 | 24853884 | Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women. | Endocrine | 2015 | https://conductscience.org/library/papers/24853884 | PubMed |
| 5 | 38211965 | SIRT1 activation promotes bone repair by enhancing the coupling of type H vessel formation and osteogenesis. | Cell Prolif | 2024 | https://conductscience.org/library/papers/38211965 | PubMed |
| 6 | 34670596 | Klotho and SIRT1 changes from pre-diabetes to diabetes and pre-hypertension to hypertension. | Diabetol Metab Syndr | 2021 | https://conductscience.org/library/papers/34670596 | PubMed |
| 7 | 26004392 | Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy. | Metabolism | 2015 | https://conductscience.org/library/papers/26004392 | PubMed |
| 8 | 39173634 | Advanced glycation end products mediate biomineralization disorder in diabetic bone disease. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/39173634 | PubMed |
| 9 | 35574058 | Reversing the imbalance in bone homeostasis via sustained release of SIRT-1 agonist to promote bone healing under osteoporotic condition. | Bioact Mater | 2023 | https://conductscience.org/library/papers/35574058 | PubMed |
| 10 | 36632457 | Novel Role of the SIRT1 in Endocrine and Metabolic Diseases. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/36632457 | PubMed |
| 11 | 34887866 | SIRT1: A Potential Therapeutic Target in Autoimmune Diseases. | Front Immunol | 2021 | https://conductscience.org/library/papers/34887866 | PubMed |
| 12 | 38104246 | SIRT1 and miR-34a-5p: Valuable Biomarkers for the Early Detection of Cognitive Impairment in Type 2 Diabetes Mellitus. | J Clin Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38104246 | PubMed |
| 13 | 18980242 | HDL3 reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells: a protection against cell death. | J Cell Biochem | 2008 | https://conductscience.org/library/papers/18980242 | PubMed |
| 14 | 25089632 | Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes. | Antioxid Redox Signal | 2014 | https://conductscience.org/library/papers/25089632 | PubMed |
| 15 | 38739545 | Inhibition of de novo ceramide synthesis by sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes. | Cardiovasc Res | 2024 | https://conductscience.org/library/papers/38739545 | PubMed |
| 16 | 35359990 | Regulation of SIRT1 and Its Roles in Inflammation. | Front Immunol | 2022 | https://conductscience.org/library/papers/35359990 | PubMed |
| 17 | 32708317 | Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32708317 | PubMed |
| 18 | 31722013 | Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL. | Clin Sci (Lond) | 2019 | https://conductscience.org/library/papers/31722013 | PubMed |
| 19 | 39199358 | Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199358 | PubMed |
| 20 | 30972029 | Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function. | Front Endocrinol (Lausanne) | 2019 | https://conductscience.org/library/papers/30972029 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42576520 | The Mechanism of Icariin in Regulating BMSCs for Treating Osteoporosis: A Review. | Endocr Metab Immune Disord Drug Targets | 2026 | https://conductscience.org/library/papers/42576520 | PubMed |
| 41221494 | The Critical Role of Autophagy in the Pathogenesis of Diabetic Osteoporosis: Mechanisms and Therapeutic Measures. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41221494 | PubMed |
| 41009597 | Elevated Sirtuin 1 Levels in Patients with Chronic Kidney Disease, Including on Peritoneal Dialysis: Associations with Cardiovascular Risk and Peritoneal Fibrosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009597 | PubMed |
| 40728546 | Inhibition of GPR75 Alleviates Lipid Metabolism by Activating the AMPK-SIRT1 Signaling Pathway In Vitro and In Vivo. | Mol Biotechnol | 2026 | https://conductscience.org/library/papers/40728546 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BGLAP | 632 | PubTator's text mining | https://conductscience.org/library/genes/632 | NCBI Gene |
| SIRT1 | 23411 | PubTator's text mining | https://conductscience.org/library/genes/23411 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39944232
GET https://conductscience.org/api/papers/v1/39944232/references?page=2